Omeprazole vs Pantoprazole: Comparing PPIs in Australia

Proton pump inhibitors (PPIs) are among the most widely prescribed medications in Australia. Omeprazole and pantoprazole are the two most common, and GPs are frequently asked which one is "better." The short answer: they are very similar in effectiveness, but differ in drug interactions, formulation, and PBS listing. This guide covers the clinically relevant differences.

How PPIs Work

PPIs irreversibly block the hydrogen-potassium ATPase enzyme (the proton pump) in the stomach lining. This is the final step of acid secretion. By blocking this pump, PPIs reduce stomach acid production by approximately 90% when taken at full dose. All PPIs work by the same mechanism -- the differences are pharmacokinetic (how the body processes them), not pharmacodynamic (what they do).

Omeprazole

Omeprazole was the first PPI, approved in Australia in 1988. It remains one of the most prescribed medications in the country.

• Doses: 10mg, 20mg, 40mg capsules
• Standard dose: 20mg once daily, taken 30-60 minutes before breakfast
• Metabolism: primarily through CYP2C19 and CYP3A4 liver enzymes
• Drug interactions: moderate -- interacts with clopidogrel (Plavix), some antifungals, and warfarin. The clopidogrel interaction is the most clinically significant
• PBS listed: Yes, for GORD, peptic ulcer, and H. pylori eradication
• Available OTC: Yes, omeprazole 10mg and 20mg are available over-the-counter (S3) from pharmacies

Pantoprazole

Pantoprazole is a newer PPI that gained popularity partly because of its cleaner drug interaction profile.

• Doses: 20mg, 40mg tablets
• Standard dose: 40mg once daily, taken 30-60 minutes before breakfast
• Metabolism: primarily through CYP2C19 but with less competitive inhibition than omeprazole
• Drug interactions: fewer than omeprazole. Importantly, pantoprazole has minimal interaction with clopidogrel -- this is a key clinical advantage for patients on antiplatelet therapy
• PBS listed: Yes, for GORD, peptic ulcer, and H. pylori eradication
• Available OTC: Yes, pantoprazole 20mg is available over-the-counter (S3)

Effectiveness: Are They Equally Good?

For the most common indications -- gastro-oesophageal reflux disease (GORD), peptic ulcers, and H. pylori eradication (with antibiotics) -- meta-analyses show no clinically significant difference in effectiveness between omeprazole and pantoprazole at equivalent doses. Healing rates for oesophagitis and symptom relief for reflux are essentially identical.

The Clopidogrel Question

This is the most important clinical difference. Clopidogrel (Plavix) is an antiplatelet medication used after heart attacks, stents, and strokes. Clopidogrel is a prodrug that requires activation by CYP2C19 -- the same enzyme that metabolises omeprazole. Concurrent omeprazole use can reduce clopidogrel's antiplatelet effect, potentially increasing cardiovascular risk.

Pantoprazole has a weaker interaction with CYP2C19 and is the preferred PPI for patients taking clopidogrel. Australian Therapeutic Guidelines recommend pantoprazole (or rabeprazole) over omeprazole for patients on concurrent antiplatelet therapy.

Side Effects

Side effect profiles are very similar between the two PPIs. Most side effects are class effects (shared by all PPIs) rather than specific to one drug.

• Headache
• Nausea, diarrhoea, constipation, or abdominal pain
• Flatulence

• Vitamin B12 deficiency: reduced acid impairs B12 absorption. Monitor after 2+ years
• Magnesium deficiency: rare but can occur with prolonged use (>1 year). Symptoms include muscle cramps, tremor, palpitations
• Calcium absorption: reduced acid may impair calcium absorption, potentially increasing fracture risk with long-term use (evidence is mixed)
• C. difficile infection: reduced stomach acid may increase susceptibility. Relevant mainly in hospital/aged care settings
• Rebound acid hypersecretion: stopping a PPI abruptly after prolonged use can cause temporary worsening of symptoms. Taper the dose gradually

PBS Status and Cost

• Both are PBS listed for GORD, peptic ulcer, and H. pylori eradication
• PBS co-payment applies (general or concession rate)
• OTC omeprazole/pantoprazole: approximately $8-$20 for 14-28 tablets
• Generic versions of both are widely available and bioequivalent

When to Use PPIs -- and When to Stop

PPIs are highly effective but are often continued longer than necessary. Australian Therapeutic Guidelines recommend the lowest effective dose for the shortest duration. Many patients can step down from a full-dose PPI to a half-dose, then to as-needed use, or discontinue entirely with lifestyle modifications.

• Barrett's oesophagus (ongoing acid suppression recommended)
• Severe erosive oesophagitis that relapses on stepping down
• Concurrent NSAID use in patients at high GI bleeding risk
• Zollinger-Ellison syndrome

• Elevate the head of the bed (not just extra pillows -- raise the frame)
• Avoid eating within 2-3 hours of lying down
• Reduce caffeine, alcohol, chocolate, and spicy foods if they trigger symptoms
• Achieve a healthy weight -- excess abdominal fat increases reflux
• Stop smoking

Getting a PPI Prescribed or Renewed

Low-dose omeprazole (10-20mg) and pantoprazole (20mg) are available without a prescription from pharmacies. Higher doses and PBS-subsidised supplies require a doctor's prescription. For ongoing repeat prescriptions of an established PPI, telehealth is a convenient option.